Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Neutrophil PAD4: How Does it Function in Cancer Beyond Promoting NETosis?

News

October 30, 2023
PRESS RELEASE: On March 24, 2023, a new editorial was published in Oncotarget, entitled, “Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?” continue reading »

Genetic Modifiers of p53 and Their Potential in Breast Cancer Therapies

News

October 25, 2023
PRESS RELEASE: On March 24, 2023, a new editorial perspective was published in Oncotarget, entitled, “Genetic modifiers of p53: opportunities for breast cancer therapies.” continue reading »

Apoptotic Cells May Drive Cell Death in Hair Follicles During Regression Cycle

News

October 23, 2023
PRESS RELEASE: On October 19, 2023, a new research paper was published in Oncotarget, entitled, “Apoptotic cells may drive cell death in hair follicles during their regression cycle.” continue reading »

How a Metabolic Enzyme Can Trigger Cell Death in Liver Cancer Cells

Oncotarget

October 19, 2023
In a new editorial paper, researchers highlight the role of GLS2 in regulating ferroptosis in hepatocellular carcinoma. continue reading »

GLS2 Shapes Ferroptosis in Hepatocellular Carcinoma

News

October 19, 2023
PRESS RELEASE: On October 19, 2023, a new editorial was published in Oncotarget, entitled, “GLS2 shapes ferroptosis in hepatocellular carcinoma.” continue reading »